BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36221793)

  • 1. Stabilization of estrogen receptor α by USP37 contributes to the progression of breast cancer.
    Cao J; Wang X; Wang S; Chen Z; Tang J
    Cancer Sci; 2023 May; 114(5):2041-2052. PubMed ID: 36221793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MINDY1 promotes breast cancer cell proliferation by stabilizing estrogen receptor α.
    Tang J; Luo Y; Long G; Zhou L
    Cell Death Dis; 2021 Oct; 12(10):937. PubMed ID: 34645792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OTUD7B stabilizes estrogen receptor α and promotes breast cancer cell proliferation.
    Tang J; Wu Z; Tian Z; Chen W; Wu G
    Cell Death Dis; 2021 May; 12(6):534. PubMed ID: 34035221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deubiquitination and stabilization of estrogen receptor α by ubiquitin-specific protease 7 promotes breast tumorigenesis.
    Xia X; Liao Y; Huang C; Liu Y; He J; Shao Z; Jiang L; Dou QP; Liu J; Huang H
    Cancer Lett; 2019 Nov; 465():118-128. PubMed ID: 31518603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ubiquitin ligase RNF2 stabilizes ERα and modulates breast cancer progression.
    Yuan L; Li X; Yang H; Li H
    Hum Cell; 2023 Jan; 36(1):353-365. PubMed ID: 36271315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
    Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
    BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development.
    Thaler S; Schmidt M; Schad A; Sleeman JP
    Oncogene; 2012 Nov; 31(47):4912-22. PubMed ID: 22266866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM11 promotes breast cancer cell proliferation by stabilizing estrogen receptor α.
    Tang J; Luo Y; Tian Z; Liao X; Cui Q; Yang Q; Wu G
    Neoplasia; 2020 Sep; 22(9):343-351. PubMed ID: 32599554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
    Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
    Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer.
    Lettlova S; Brynychova V; Blecha J; Vrana D; Vondrusova M; Soucek P; Truksa J
    Cell Physiol Biochem; 2018; 46(6):2601-2615. PubMed ID: 29763890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. USP37 downregulation elevates the Chemical Sensitivity of Human Breast Cancer Cells to Adriamycin.
    Qin T; Cui XY; Xiu H; Huang C; Sun ZN; Xu XM; Li LH; Yue L
    Int J Med Sci; 2021; 18(2):325-334. PubMed ID: 33390801
    [No Abstract]   [Full Text] [Related]  

  • 12. Abnormally elevated USP37 expression in breast cancer stem cells regulates stemness, epithelial-mesenchymal transition and cisplatin sensitivity.
    Qin T; Li B; Feng X; Fan S; Liu L; Liu D; Mao J; Lu Y; Yang J; Yu X; Zhang Q; Zhang J; Song B; Li M; Li L
    J Exp Clin Cancer Res; 2018 Nov; 37(1):287. PubMed ID: 30482232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PSMD14 stabilizes estrogen signaling and facilitates breast cancer progression via deubiquitinating ERα.
    Yang P; Yang X; Wang D; Yang H; Li Z; Zhang C; Zhang S; Zhu J; Li X; Su P; Zhuang T
    Oncogene; 2024 Jan; 43(4):248-264. PubMed ID: 38017133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation.
    Zhu J; Zhao C; Kharman-Biz A; Zhuang T; Jonsson P; Liang N; Williams C; Lin CY; Qiao Y; Zendehdel K; Strömblad S; Treuter E; Dahlman-Wright K
    Oncogene; 2014 Aug; 33(34):4340-51. PubMed ID: 24441041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. USP35, regulated by estrogen and AKT, promotes breast tumorigenesis by stabilizing and enhancing transcriptional activity of estrogen receptor α.
    Cao J; Wu D; Wu G; Wang Y; Ren T; Wang Y; Lv Y; Sun W; Wang J; Qian C; He L; Yang K; Li H; Gu H
    Cell Death Dis; 2021 Jun; 12(6):619. PubMed ID: 34131114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ERα in SUM-44 breast cancer cells and is associated with ERα over-expression in breast cancer.
    Irish JC; Mills JN; Turner-Ivey B; Wilson RC; Guest ST; Rutkovsky A; Dombkowski A; Kappler CS; Hardiman G; Ethier SP
    Mol Oncol; 2016 Jun; 10(6):850-65. PubMed ID: 27005559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase D1 regulates ERα-positive breast cancer cell growth response to 17β-estradiol and contributes to poor prognosis in patients.
    Karam M; Bièche I; Legay C; Vacher S; Auclair C; Ricort JM
    J Cell Mol Med; 2014 Dec; 18(12):2536-52. PubMed ID: 25287328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZBTB7A governs estrogen receptor alpha expression in breast cancer.
    Molloy ME; Lewinska M; Williamson AK; Nguyen TT; Kuser-Abali G; Gong L; Yan J; Little JB; Pandolfi PP; Yuan ZM
    J Mol Cell Biol; 2018 Aug; 10(4):273-284. PubMed ID: 30265334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression.
    Xia X; Huang C; Liao Y; Liu Y; He J; Shao Z; Hu T; Yu C; Jiang L; Liu J; Huang H
    Cell Death Dis; 2021 Mar; 12(4):329. PubMed ID: 33771975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autocrine regulation of cell proliferation by estrogen receptor-alpha in estrogen receptor-alpha-positive breast cancer cell lines.
    Tan H; Zhong Y; Pan Z
    BMC Cancer; 2009 Jan; 9():31. PubMed ID: 19171042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.